Gestational hypertension and severe preeclampsia are serious conditions that can develop during pregnancy, characterized by high blood pressure and potential organ damage. Managing these disorders effectively is crucial to protect both mother and baby from complications such as preterm birth, placental abruption, or eclampsia. Nifedipine is a calcium channel blocker commonly used to control blood pressure in pregnant women diagnosed with these conditions. It works by relaxing the smooth muscles of blood vessels, thereby lowering blood pressure and improving blood flow without adversely affecting uterine contractions. This makes nifedipine a preferred medication in acute management. When treating gestational hypertension or severe preeclampsia, healthcare providers carefully monitor blood pressure levels and symptoms to determine the appropriate dosage and treatment duration of nifedipine. In some cases, nifedipine is combined with other antihypertensive medications based on the patient’s response and specific health considerations. It is important for patients to attend regular prenatal appointments and report any new symptoms, such as severe headaches, visual disturbances, or abdominal pain, as these may indicate worsening preeclampsia that requires prompt intervention. Additionally, lifestyle modifications, including reduced salt intake, adequate hydration, and rest, complement the pharmacological approach. Despite its benefits, nifedipine treatment must be managed under medical supervision due to potential side effects such as dizziness or swelling. Each pregnancy is unique, and individualized care plans ensure optimal outcomes. Ultimately, a comprehensive approach combining medication like nifedipine and close monitoring helps reduce risks associated with gestational hypertension and severe preeclampsia, supporting a safer pregnancy journey for mothers and their babies.